1. Azevedo R, Peixoto A, Gaiteiro C, Fernandes E, Neves M, Lima L, Santos LL, Ferreira JA

Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology? Oncotarget 8: 91734-91764, 2017.  [Review] 

 doi: 10.18632/oncotarget.19433 PMID: 29207682.

 

2. Azevedo R, Soares J, Gaiteiro C, Peixoto A, Lima L, Ferreira D, Relvas-Santos M, Fernandes E, Tavares A, Cotton S, Daniel-da-Silva AL, Santos LL, Vitorino R, Amado F, Ferreira JA

Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer. Talanta 184: 347-355, 2018.  [Article] 

 doi: 10.1016/j.talanta.2018.03.028 PMID: 29674052.

 

3. Loureiro LR, Sousa DP, Ferreira D, Chai W, Lima L, Pereira C, Lopes CB, Correia VG, Silva LM, Li C, Santos LL, Ferreira JA, Barbas A, Palma AS, Novo C, Videira PA

Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids. Scientific reports 8: 12196, 2018.  [Article] 

 doi: 10.1038/s41598-018-30421-w PMID: 30111774.

 

4. Neves M, Azevedo R, Lima L, Oliveira MI, Peixoto A, Ferreira D, Soares J, Fernandes E, Gaiteiro C, Palmeira C, Cotton S, Mereiter S, Campos D, Afonso LP, Ribeiro R, Fraga A, Tavares A, Mansinho H, Monteiro E, Videira PA, Freitas PP, Reis CA, Santos LL, Dieguez L, Ferreira JA

Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications. New biotechnology 49: 77-87, 2019.  [Article; Proceedings Paper] 

 doi: 10.1016/j.nbt.2018.09.004 PMID: 30273682.

 

5. Lima L, Neves M, Oliveira MI, Dieguez L, Freitas R, Azevedo R, Gaiteiro C, Soares J, Ferreira D, Peixoto A, Fernandes E, Montezuma D, Tavares A, Ribeiro R, Castro A, Oliveira M, Fraga A, Reis CA, Santos LL, Ferreira JA

Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases. Urologic oncology 35: 675.e1-675.e8, 2017.  [Article] 

 doi: 10.1016/j.urolonc.2017.08.012 PMID: 28911924.

 

6. Azevedo R, Soares J, Peixoto A, Cotton S, Lima L, Santos LL, Ferreira JA

Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology. Urologic oncology 36: 221-236, 2018.  [Review] 

 doi: 10.1016/j.urolonc.2018.02.004 PMID: 29530466.

 

7. Costa C, Pereira S, Lima L, Peixoto A, Fernandes E, Neves D, Neves M, Gaiteiro C, Tavares A, Gil da Costa RM, Cruz R, Amaro T, Oliveira PA, Ferreira JA, Santos LL

Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics. PloS one 10: e0141253, 2015.  [Article] 

 doi: 10.1371/journal.pone.0141253 PMID: 26569621.